AMRX vs. AXP

In the year-to-date period, AMRX achieves a -1.14% return, which is significantly lower than AXP's -0.23% return. Over the past 10 years, AMRX has underperformed AXP with an annualized return of -15.21%, while AXP has yielded a comparatively higher 15.55% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Amneal Pharmaceuticals, Inc. (AMRX) and American Express Company (AXP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current AMRX Sharpe Ratio is 0.94, which is lower than the AXP Sharpe Ratio of 1.70. The chart below compares the historical Sharpe Ratios of AMRX and AXP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

AMRX has not paid dividends to shareholders, while AXP's dividend yield for the trailing twelve months is around 0.95%.

The maximum AMRX drawdown since its inception was -97.52%, which is greater than AXP's maximum drawdown of -83.91%. Use the drawdown chart below to compare losses from any high point for AMRX and AXP. For additional features, visit the drawdowns tool.

Amneal Pharmaceuticals, Inc. (AMRX) has a higher volatility of 7.44% compared to American Express Company (AXP) at 5.36%. This indicates that AMRX's price experiences larger fluctuations and is considered to be riskier than AXP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Amneal Pharmaceuticals, Inc. and American Express Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.